|
MDGL
|
Madrigal Pharmaceuticals, Inc.
|
3.97%
|
US
|
NASDAQ
|
|
IMAB
|
I-Mab
|
1.19%
|
US
|
NASDAQ
|
|
CVAC
|
CureVac N.V.
|
1.17%
|
US
|
NASDAQ
|
|
FGEN
|
FibroGen, Inc
|
1.07%
|
US
|
NASDAQ
|
|
ALT
|
Altimmune, Inc.
|
1.05%
|
US
|
NASDAQ
|
|
TGTX
|
TG Therapeutics, Inc.
|
1.03%
|
US
|
NASDAQ
|
|
GERN
|
Geron Corporation
|
1.02%
|
US
|
NASDAQ
|
|
IMVT
|
Immunovant, Inc.
|
1.01%
|
US
|
NASDAQ
|
|
VRDN
|
Viridian Therapeutics, Inc.
|
0.96%
|
US
|
NASDAQ
|
|
BTAI
|
BioXcel Therapeutics, Inc.
|
0.95%
|
US
|
NASDAQ
|
|
RAPT
|
RAPT Therapeutics, Inc.
|
0.93%
|
US
|
NASDAQ
|
|
PTGX
|
Protagonist Therapeutics, Inc.
|
0.93%
|
US
|
NASDAQ
|
|
KOD
|
Kodiak Sciences Inc
|
0.92%
|
US
|
NASDAQ
|
|
SWTX
|
SpringWorks Therapeutics, Inc.
|
0.91%
|
US
|
NASDAQ
|
|
CERE
|
Cerevel Therapeutics Holdings, Inc.
|
0.91%
|
US
|
NASDAQ
|
|
CLDX
|
Celldex Therapeutics, Inc.
|
0.90%
|
US
|
NASDAQ
|
|
MRUS
|
Merus N.V.
|
0.89%
|
US
|
NASDAQ
|
|
RETA
|
Reata Pharmaceuticals, Inc. - Class A
|
0.87%
|
US
|
NASDAQ
|
|
CYTK
|
Cytokinetics, Incorporated
|
0.83%
|
US
|
NASDAQ
|
|
CRNX
|
Crinetics Pharmaceuticals, Inc.
|
0.83%
|
US
|
NASDAQ
|